Biopharma Thought Leadership Blog

Explore blog posts from our AGC Biologics scientific experts sharing insights and innovations on drug development and manufacturing strategies.

AGC Bio team members collaborating in laboratory wearing PPE equipment.

2 min read

CTO Interview: Managing Outsourcing in 2023

March 16, 2023 at 6:56 PM

Thought Leadership Blog

Read article

CDMO Outsourcing Trends and Benefits in the Biologics Manufacturing Industry

2 min read

CDMO Outsourcing Trends & Benefits in Biologics Manufacturing Industry

March 14, 2023 at 7:47 AM

Thought Leadership Blog

Read article

Close-up of cells being worked with in controlled environment under a hood by a scientist in PPE.

1 min read

3 Important Factors Driving Orphan Drug Development & Manufacturing

February 27, 2023 at 5:56 PM

Thought Leadership Blog Cell & Gene Therapy

Read article

Resin vs. Protein A Membrane for Monoclonal Antibody Purification

2 min read

Comparing Antibody Purification Methods: Protein A vs. Resin

February 24, 2023 at 12:18 PM

Thought Leadership Blog Mammalian & mAbs Process Development

Read article

Upstream process development scientist working with single-use bioreactors for mammalian cell manufacturing.

1 min read

AGC Biologics is Doubling Mammalian Capacity in Europe

January 9, 2023 at 1:43 PM

Read article

1 min read

White Paper: Producing Customized Viral Vectors that Respond to Market Demands

December 8, 2022 at 7:11 AM

Read article

Female scientist smiling while working with pipette and other equipment.

CDMO Services: mRNA and pDNA Production and Manufacturing

October 10, 2022 at 1:23 PM

Read article

AGC Biologics Process Development for biologics

2 min read

Single-Use Technology and Downstream Processing in the Age of Precision Medicine

September 29, 2022 at 2:34 PM

Thought Leadership Blog Mammalian & mAbs

Read article

Two individuals testing materials on lab equipment

1 min read

AGC Biologics Hosts Tours of Viral Vectors Production Facility at Milan site for European Biotech Week 2022

September 1, 2022 at 6:15 AM

Read article

1 min read

Case Study: How to get from Low Yield to Robust Manufacturing

August 11, 2022 at 10:52 AM

Thought Leadership Blog

Read article

Prev 3 4 5 6 7 Next

Our Company

Locations

Policies

Offerings

Services

Specialized Platforms & Programs

News & Blogs

Resources

Fact Sheet Quick Links

Join Us

What Drives Us

Meet Our Teams

Biopharma Thought Leadership Blog

CTO Interview: Managing Outsourcing in 2023

CDMO Outsourcing Trends & Benefits in Biologics Manufacturing Industry

3 Important Factors Driving Orphan Drug Development & Manufacturing

Comparing Antibody Purification Methods: Protein A vs. Resin

AGC Biologics is Doubling Mammalian Capacity in Europe

White Paper: Producing Customized Viral Vectors that Respond to Market Demands

CDMO Services: mRNA and pDNA Production and Manufacturing

Single-Use Technology and Downstream Processing in the Age of Precision Medicine

AGC Biologics Hosts Tours of Viral Vectors Production Facility at Milan site for European Biotech Week 2022

Case Study: How to get from Low Yield to Robust Manufacturing

Our Mission

Links

News

AGC Biologics’ Milan Site to Prepare Lentiviral Vector Commercial Manufacturing for Adaptimmune’s Lete-Cel Product

Events

Advanced Therapies Congress, March 18-19